JP2005530809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005530809A5 JP2005530809A5 JP2004507430A JP2004507430A JP2005530809A5 JP 2005530809 A5 JP2005530809 A5 JP 2005530809A5 JP 2004507430 A JP2004507430 A JP 2004507430A JP 2004507430 A JP2004507430 A JP 2004507430A JP 2005530809 A5 JP2005530809 A5 JP 2005530809A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- group
- phenoxy
- therapeutic
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0206561A FR2840301B1 (fr) | 2002-05-29 | 2002-05-29 | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique |
| PCT/FR2003/001580 WO2003099772A1 (fr) | 2002-05-29 | 2003-05-26 | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005530809A JP2005530809A (ja) | 2005-10-13 |
| JP2005530809A5 true JP2005530809A5 (https=) | 2006-07-13 |
| JP4393376B2 JP4393376B2 (ja) | 2010-01-06 |
Family
ID=29558808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004507430A Expired - Fee Related JP4393376B2 (ja) | 2002-05-29 | 2003-05-26 | フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7453010B2 (https=) |
| EP (1) | EP1511722B1 (https=) |
| JP (1) | JP4393376B2 (https=) |
| AT (1) | ATE374748T1 (https=) |
| AU (1) | AU2003263229A1 (https=) |
| DE (1) | DE60316683T2 (https=) |
| FR (1) | FR2840301B1 (https=) |
| WO (1) | WO2003099772A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2817257B1 (fr) * | 2000-11-30 | 2009-03-20 | Sanofi Synthelabo | Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant |
| US7795283B2 (en) * | 2004-12-14 | 2010-09-14 | Astrazeneca Ab | Oxadiazole derivative as DGAT inhibitors |
| US7749997B2 (en) * | 2005-12-22 | 2010-07-06 | Astrazeneca Ab | Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
| WO2007138304A1 (en) | 2006-05-30 | 2007-12-06 | Astrazeneca Ab | 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
| JP2009538892A (ja) | 2006-05-30 | 2009-11-12 | アストラゼネカ アクチボラグ | アセチル補酵素ａジアシルグリセロールアシルトランスフェラーゼの阻害薬としての置換５−フェニルアミノ−１，３，４−オキサジアゾール−２−イルカルボニルアミノ−４−フェノキシ−シクロヘキサンカルボン酸 |
| ES2359653T3 (es) * | 2006-06-08 | 2011-05-25 | Astrazeneca Ab | Bencimidazoles y su uso para el tratamiento de la diabetes. |
| GB0611507D0 (en) * | 2006-06-10 | 2006-07-19 | Astrazeneca Ab | Chemical compounds |
| EP2011490A1 (en) * | 2007-07-05 | 2009-01-07 | Sanofi-Aventis | Beta adrenergic receptor ligand derivatives for modulating apoptosis |
| WO2009024821A2 (en) * | 2007-08-17 | 2009-02-26 | Astrazeneca Ab | Oxadiazole derivatives as dgat inhibitors |
| EP2234978B1 (en) | 2007-12-20 | 2015-02-25 | AstraZeneca AB | Carbamoyl compounds as dgat1 inhibitors 190 |
| FR2935141B1 (fr) * | 2008-08-21 | 2010-10-08 | Sanofi Aventis | Procede de preparation de l'ester ethylique de l'acide 4-[trans-4-[(phenylmethyl)-amino]cyclohexyl]benzoique et de son sel hemifumarate |
| BRPI0924669A2 (pt) * | 2008-12-19 | 2016-01-26 | Astrazeneca Ab | composto, uso de um composto, método para tratar a diabete melito e/ou obesidade, e, composição farmacêutica |
| NZ594244A (en) | 2009-01-28 | 2013-07-26 | Sanofi Sa | Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof |
| BRPI1016109A2 (pt) | 2009-06-19 | 2016-05-17 | Astrazeneca Ab | "composto, composição farmacêutica, e, processo para preparar um composto" |
| FR2963005B1 (fr) | 2010-07-23 | 2012-08-17 | Sanofi Aventis | Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4004028A (en) * | 1975-08-06 | 1977-01-18 | Smithkline Corporation | Phenoxypropanolamines |
| CN1023402C (zh) * | 1988-06-03 | 1994-01-05 | 伊莱利利公司 | 制备5-羟色胺拮抗药的方法 |
| FR2780057B1 (fr) * | 1998-06-18 | 2002-09-13 | Sanofi Sa | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2817257B1 (fr) * | 2000-11-30 | 2009-03-20 | Sanofi Synthelabo | Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant |
-
2002
- 2002-05-29 FR FR0206561A patent/FR2840301B1/fr not_active Expired - Fee Related
-
2003
- 2003-05-26 DE DE60316683T patent/DE60316683T2/de not_active Expired - Lifetime
- 2003-05-26 AU AU2003263229A patent/AU2003263229A1/en not_active Abandoned
- 2003-05-26 JP JP2004507430A patent/JP4393376B2/ja not_active Expired - Fee Related
- 2003-05-26 WO PCT/FR2003/001580 patent/WO2003099772A1/fr not_active Ceased
- 2003-05-26 AT AT03755202T patent/ATE374748T1/de not_active IP Right Cessation
- 2003-05-26 EP EP03755202A patent/EP1511722B1/fr not_active Expired - Lifetime
- 2003-05-26 US US10/515,145 patent/US7453010B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU700580B2 (en) | Aryloxypropanolamine beta 3 adrenergic agonists | |
| JP2005530809A5 (https=) | ||
| AU758758B2 (en) | Substituted oxazoles and thiazoles derivatives as HPPAR alpha activators | |
| JP6506836B2 (ja) | Ｂ型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン | |
| JP3490704B2 (ja) | チアゾールおよびオキサゾール誘導体ならびにそれらの医薬的使用 | |
| HU218276B (en) | Carbonyl-amino-thiazole derivatives substituted with heterocyclic group, pharmaceutical compositions comprising such compounds as active ingredient, as well as process for producing them | |
| CA2433100A1 (en) | Indole derivatives as ligands of thyroid receptors | |
| JP7656669B2 (ja) | マトリックスメタロプロテイナーゼ（ｍｍｐ）阻害剤及びその使用方法 | |
| CZ300131B6 (cs) | Zpusob prípravy meziproduktu inhibujících proteázy retroviru | |
| JP2003517013A (ja) | フェノキシプロパノールアミン類、それらの製造方法およびそれらを含む医薬組成物 | |
| BG61692B1 (bg) | Съединения с ангиотензин ii антагонистична активност | |
| JP4393376B2 (ja) | フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用 | |
| WO2012153158A1 (en) | Process for the manufacture of dabigatran etexilate and intermediates thereof | |
| IE881716L (en) | Preparation of oxophthalazinyl acetic acids | |
| JP2012511514A (ja) | レニン阻害剤としての３，４−置換ピペリジン誘導体 | |
| EA025216B1 (ru) | Производное 5-замещенной индол-3-карбоновой кислоты, обладающее противовирусным действием в отношении вируса гриппа а | |
| CN101304984A (zh) | 唑和噻唑ppar调节剂 | |
| AU2003266052A1 (en) | Cathepsin cysteine protease inhibitors | |
| JPS5988467A (ja) | フエノキシアミノプロパノ−ル誘導体 | |
| US7425639B2 (en) | Process | |
| CN115667227B (zh) | 基质金属蛋白酶(mmp)抑制剂及其使用方法 | |
| IE61393B1 (en) | Cyclobutenediones useful as intermediates | |
| CN108610333A (zh) | 诱导MDM2自我降解E3泛素连接酶二聚体酰胺类小分子PROTACs | |
| JP2001502686A (ja) | Ｎ▲下α▼―２―（４―ニトロフェニルスルホニル）エトキシカルボニル―アミノ酸 | |
| JP2005535599A5 (https=) |